Frontier
Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Oct 27, 2021; 13(10): 1110-1121
Published online Oct 27, 2021. doi: 10.4240/wjgs.v13.i10.1110
Table 1 Summary of comparative studies: Operative outcomes
Ref. Blood loss in mL /transfused % Resection margin in mm R0 resection rate % LLR OLR P LLR OLR P LLR OLR P Belli et al [5 ] 297 580 < 0.001 100 93.6 0.057 Tranchart et al [6 ] 364.3 723.7 < 0.0001 10.4 10.6 NS Lee et al [7 ] 150 240 NS 1.8 1.05 0.016 97 98 NS Ahn et al [8 ] 350 355 NS 17 13 NS Memeo et al [9 ] 200 200 NS 10 6 0.02 Lee et al [10 ] 300 700 0.004 13 10 0.25 Yoon et al [11 ] 3.4% 7.5% 0.04 2.03 1.12 0.01 Xiao et al [12 ] 272 450 0.001 100 98 NS Sposito et al [13 ] NS 6 5 NS 98 98 NS Cheung et al [14 ] 100 300 < 0.001 100 93.1 NS Ryu et al [15 ] 95 83 NS Rhu et al [16 ] 13% 2% NS 13 12 NS Guro et al [17 ] 1543 1248 97.6 94.6 NS El-Gendi et al [18 ] 230 250 NS 100 100 NS Inoue et al [19 ] 100 380 < 0.0001 7 5 NS Kim et al [20 ] 300 250 NS 13 15 NS Deng et al [21 ] 150 380 < 0.001 98 90 NS Wu et al [22 ] 150 250 NS Tsai et al [23 ] 363 839 < 0.001 5 5.2 NS Di Sandro et al [24 ] 150 200 0.007 5 5 NS Li et al [25 ] 328 396 NS Kim et al [26 ] 152 245 8.5 8.4 NS Chen et al [27 ] 300 500 < 0.1 97 100 NS Untereiner et al [28 ] 150 250 NS 91 85 NS Yoon et al [29 ] 226 251 98 98 Peng et al [30 ] 200 300 NS 100 100 NS Yamamoto et al [31 ] 87 223 3 3 NS Lee et al [32 ] 19% 28% NS 9 16.5 NS Navarro et al [33 ] 234 454 0.021 100 100 NS Delvecchio et al [34 ] 13% 25% NS 95 87 NS Ho et al [35 ] 500 725 NS 5 3 0.043 91 91 NS
Table 2 Summary of comparative studies: Baseline clinical-pathological features of both treatment groups
Ref. Difference between study groups ICG, % Child A/B/C, % Tumor size in cm Microvascular invasion, % LLR OLR LLR OLR LLR +/- SD/95%CI OLR +/- SD/95%CI LLR OLR Belli et al [5 ] Tumor size, AFP level, margin width 91/9/0 93.6/6.4/0 3.8 +/-1.3 6 +/-2.3 37 39.2 Tranchart et al [6 ] 3.6 +/-1.75 3.7 +/-2.1 33.3 35.7 Lee et al [7 ] Cirrhosis, previous abdominal surgery, margin width 2.5 1.5-9 2.9 1.2-9 Ahn et al [8 ] 14.5 13.1 2.6 +/-1.5 2.8 +/-1.2 15.7 19.6 Memeo et al [9 ] Margin width 98/2/0 96/4/0 3.2 0.9-11 3.7 0.1-15 Lee et al [10 ] Margin width 97.6/2.4/0 97.6/2.4/0 5.4 2-16 4.4 2-14 52.5 43.5 Yoon et al [11 ] Margin width 12.1 12.4 2.87 0.7-4.9 3.04 0.2-4.9 Xiao et al [12 ] 95/5/0 96.5/3.5/0 4.22 +/-2.05 4.3 +/-1.49 Sposito et al [13 ] 15 15 98/2/0 95/5/0 2.6 1-6.5 2.2 1-8.5 56 37 Cheung et al [14 ] Age 100/0/0 96.6/3.4/0 3 1.2-5 3.5 1.5-8.5 Ryu et al [15 ] 11.9 14 3.9 1.1-17 4.9 1-14.5 30 40 Rhu et al [16 ] 37.7/0/0 37.1/0/0 3.1 +/-5.7 3.1 +/-1.7 56.6 58.8 Guro et al [17 ] Cirrhosis, tumor size 95/2.4/2.4 88/9.9/7.2 4.1 +/-2.4 6.3 +/-3.8 El-Gendi et al [18 ] 100/0/0 100/0/0 3.3 +/-0.57 3.4 0.59 60 68 Inoue et al [19 ] 89/11/0 100/0/0 2.5 2.6 12 13 Kim et al [20 ] 9.3 8 2.8 2.8 25 23 Deng et al [21 ] Procedure type 100/0/0 100/0/0 2.5 2.8 10.2 16.6 Wu et al [22 ] 3.5 0.9-12.5 3.5 0.8-11.3 38.4 41.9 Tsai et al [23 ] Procedure magnitude, tumor size 93/7/0 98/2/0 3.9 +/-2.6 7.2 +/-5.3 Di Sandro et al [24 ] 87/13/0 84/16/0 2.5 2-3.0 2.5 1.8-3.3 29.3 29.3 Li et al [25 ] Tumor size 4 +/-2 5.7 +/-3 17 30 Kim et al [26 ] 10.4 12.8 3 +/-2.1 3.2 +/-3.14 22.2 27.8 Chen et al [27 ] 6.9 6.9 7.3 +/-3.4 7.6 +/-4.2 37 32 Untereiner et al [28 ] 64/0/0 73/0/0 3 2.1-4.9 3 2.3-5 Yoon et al [29 ] ASA class, medical disease 13.6 14 66.8/0/0 65.4/0/0 2.83 1.28 2.9 1.31 14.3 15.7 Peng et al [30 ] 94/6/0 91/9/0 4.8 2-8.5 5.5 2-8.5 30 30 Yamamoto et al [31 ] 88/22/0 84/16/0 1.7 1.2-4.2 2 0.7-9.9 Lee et al [32 ] 90/10/0 91/9/0 2.5 7-14.5 2.6 1.1-14.5 8.6 8.6 Navarro et al [33 ] 3.5 8.5 3.3 8.1 51.2 51.2 Delvecchio et al [34 ] 97/3/0 98/2/0 4 3.0-16 7 1.5-14 Ho et al [35 ] Hepatitis C carrier status margin width 100/0/0 92/8/0 3.5 2-5 4 3-5 28.9 30
Table 3 Summary of comparative studies: Study design
Ref. Year Number of patients Matching Study population LLR OLR Demographic Tumor Cirrhosis Procedure Belli et al [5 ] 2009 54 125 No < 5 cm, anterolaterally located Tranchart et al [6 ] 2010 42 42 Yes Lee et al [7 ] 2011 33 50 Yes Minor resection Ahn et al [8 ] 2014 51 51 Yes Solitary Memeo et al [9 ] 2014 45 45 Yes Cirrhosis Lee et al [10 ] 2015 43 86 Yes Yoon et al [11 ] 2015 58 174 Yes < 5 cm Xiao et al [12 ] 2015 41 86 No Posterosuperior Sposito et al [13 ] 2016 43 43 Yes Cirrhosis Minor resection Cheung et al [14 ] 2016 24 29 Yes Left lateral sectionectomy Ryu et al [15 ] 2018 40 30 No Anatomical resection Rhu et al [16 ] 2018 58 133 Yes Right posterior sectionectomy Guro et al [17 ] 2018 67 110 No Major hepatectomy El-Gendi et al [18 ] 2018 25 25 Randomized < 5 cm Child A Inoue et al [19 ] 2018 61 175 Yes < 5 cm Parenchymal sparing hepatectomy Kim et al [20 ] 2018 37 37 Yes Left hepatectomy Deng et al [21 ] 2018 157 157 Yes Wu et al [22 ] 2019 86 86 Yes Cirrhosis Tsai et al [23 ] 2019 153 160 Yes Di Sandro et al [24 ] 2018 75 75 Yes Cirrhosis Minor hepatectomy Li et al [25 ] 2019 41 307 Yes Mesohepatectomy Kim et al [26 ] 2018 18 36 Yes Central Chen et al [27 ] 2019 38 38 Yes Right hepatectomy Untereiner et al [28 ] 2019 33 33 Yes Yoon et al [29 ] 2020 217 434 Yes Peng et al [30 ] 2019 33 33 Yes Multiple Yamamoto et al [31 ] 2020 58 197 Yes Cirrhosis Lee et al [32 ] 2021 58 110 Yes Navarro et al [33 ] 2021 106 299 Yes Major hepatectomy Delvecchio et al [34 ] 2021 38 84 Yes Elderly Major hepatectomy Ho et al [35 ] 2021 45 90 Yes
Table 4 Summary of comparative studies: Long-term oncological outcomes
Ref. 1-year OS, % 3-year OS, % 5-year OS, % 1-year DFS, % 3-year DFS, % 5-year DFS, % LLR OLR P LLR OLR P LLR OLR P LLR OLR P LLR OLR P LLR OLR P Belli et al [5 ] 94 85 NS 67 53 NS 78 79 NS 52 52 NS Tranchart et al [6 ] 93.1 81.8 NS 74.4 73 NS 59.5 47.4 NS 81.6 70.2 NS 60.9 54.3 NS 45.6 37.2 NS Lee et al [7 ] 86.9 98 NS 81.8 80.6 NS 76 76.1 NS 78.8 69.2 NS 51 55.9 NS 45.3 55.9 NS Ahn et al [8 ] 80.1 85.7 NS 67.8 54.8 NS Memeo et al [9 ] 88 63 NS 59 44 NS 80 60 NS 19 23 NS Lee et al [10 ] 95.3 93.9 NS 89.7 89.5 NS 89.7 87.3 NS 60.5 81.5 NS 60.3 66.7 NS 60.3 58.6 NS Yoon et al [11 ] 95 98 NS 86 84 NS 82 88 NS 63 62 NS Xiao et al [12 ] 95.1 89.5 NS 78 76.7 NS 87.8 82.6 NS 70.7 68.6 NS Sposito et al [13 ] 75 79 NS 38 46 NS 41 44 NS 25 11 NS Cheung et al [14 ] 100 93 NS 85.6 84.1 NS 69.1 77.6 NS 95 69.2 NS 72.8 61.5 NS 51.8 61.5 NS Ryu et al [15 ] 89.9 89.9 NS 84.7 68 NS 70.9 63.1 NS 79.5 72.4 NS 58 56.1 NS 42.5 50.4 NS Rhu et al [16 ] 96.8 96.8 NS 94.5 94.5 NS 94.5 94.5 NS 77.8 77.8 NS 68.3 68.3 NS 62.5 62.5 NS Guro et al [17 ] 77.3 60.2 NS 50.8 40.1 NS El-Gendi et al [18 ] 88 84 NS 58.7 54 NS Inoue et al [19 ] 97.8 87.9 NS 78.8 70.6 NS 83.8 75 NS 57.5 54.8 NS Kim et al [20 ] 93.9 93.8 79.6 91.1 NS Deng et al [21 ] 96.2 96.8 NS 72.6 73.4 NS 45.3 46.9 NS 90.5 91.7 NS 53.7 54.4 NS 24.6 19.9 NS Wu et al [22 ] 93 81.4 NS 81.4 75.5 NS 69.8 62.8 NS 75.6 69.8 NS 60.5 53.5 NS 44.2 38.4 NS Tsai et al [23 ] 90.3 85 0.002 82.9 63.6 0.002 78.1 57.6 0.002 72.9 60.8 NS 49.2 43 NS 37.9 31 NS Di Sandro et al [24 ] 68 76 44 44 NS Li et al [25 ] 96.3 95.3 NS 68.4 90.5 NS 84 87.2 NS 36 59.7 NS Kim et al [26 ] 94.4 100 NS 94.4 92.9 NS 93.8 76.5 NS 56.3 41.3 NS Chen et al [27 ] 69.8 74 NS 51.6 57.8 NS Untereiner et al [28 ] 78 79 NS 72 58.6 NS Yoon et al [29 ] 98.1 93.8 NS 87 90.8 NS 78.6 84.3 NS 81 85.3 NS 62 64.7 NS 49.1 56.2 NS Peng et al [30 ] 95.8 92.8 77 77 NS 71.9 79.1 NS 51.4 46.2 NS Yamamoto et al [31 ] 82 78.4 NS 58.9 62.3 NS 52.6 40.3 NS 24 24.1 NS Lee et al [32 ] 96.6 92.8 NS 73.3 93.1 NS 88.8 76.1 NS 84.4 64 NS 60.2 93.1 NS 67.4 63.9 NS Navarro et al [33 ] 90 90 NS 58 40 NS Delvecchio et al [34 ] 100 95 NS 100 88 NS 77 75 NS 67 79 NS 44 54 NS 29 46 NS Ho et al [35 ] 95.6 87.5 0.036 84.9 70.3 0.036 84.9 61.1 0.036 80.0 73.3 NS 40.0 41.1 NS 20.0 22.2 NS